MTL has developed an advanced technology for genetically engineering superior microbial strains and protein products. The current tools are difficult to work with and yield unstable bio production systems resulting in a product development bottleneck. The company’s engine features a disruptive technology that utilizes a more efficient process to create stable bacterial strains that radically lower process development and production costs. Competing tools rely on plasmid based systems and represent 1980’s technology. The MTL technology enables enhanced microbial strain development that couples product development to production scale up. MTL also extends its stable protein expression technology to include gene/protein sequence optimization and processing optimization.
More Information: https://www.ohio.edu/research/innovation/company.cfm?company=52EE1137-5056-A81E-8D0BB528CDF899DF